- Barrons.com•3 hours ago
With the MSCI Emerging Market index up double digits this year, Morningstar says the rally “is not based on fundamentals." Investors are looking for returns in markets that have under performed in recent years, says writer Manuela Badawy, who cited a plethora of risks, from the attempted coup in Turkey that roiled markets there to fluctuating foreign exchange rates and economic risks facing commodity-dependent nations such as Nigeria and South Africa. For those investors who find the lure of higher growth in emerging markets attractive despite the risks, Morningstar's Badawy offered up a handful of stock picks and fund ideas.
- Capital Cube•5 days agoTeva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : August 22nd, 2016 (record date) : By the numbers : October 20, 2016
Categories: Yahoo Finance Get free summary analysis Our analysis is based on comparing Teva Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Sanofi Sponsored ADR, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Pfizer Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Astrazeneca PLC Sponsored ADR and Takeda Pharmaceutical ... Read more (Read more...)
- Zacks•5 days ago
Given the current scenario of increased political, media and public pressure on drug pricing, it makes sense to zero in on companies that are in the biosimilars business.